GB:DOCT ETF Price & Analysis
DOCT ETF Chart & Stats
$14.73
--
Market closed
$14.73
--
Day’s Range― - ―
52-Week Range$11.31 - $16.15
Previous Close$14.73
VolumeN/A
Average Volume (3M)4.24K
AUM242.77M
NAV14.71
Expense Ratio0.49%
Holdings Count64
Beta0.98
Inception DateJun 17, 2019
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume7,181
30 Day Avg. Volume4,236
AlphaN/A
ETF Overview
Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD
The Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD, trading under the ticker GB:DOCT, is a meticulously crafted investment vehicle designed to offer exposure to the burgeoning healthcare sector. This ETF is strategically focused on capturing growth opportunities within the health care industry, emphasizing breakthrough innovations and cutting-edge medical advancements. By targeting a broad-based niche, the fund seeks to invest in companies that are at the forefront of healthcare innovation, including those involved in biotechnology, pharmaceuticals, medical devices, and healthcare services. This forward-looking approach not only positions investors to benefit from rapid technological advancements and increased healthcare demands but also aligns with global trends towards improved health outcomes and longevity. The ETF's accumulation structure means that it reinvests dividends back into the fund, potentially enhancing compound growth over time. Ideal for investors seeking to capitalize on the dynamic and evolving landscape of healthcare breakthroughs, the L&G Healthcare Breakthrough UCITS ETF provides a compelling opportunity to be part of a sector that is integral to the future of global well-being.
Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD (DOCT) Fund Flow Chart
Legal & General UCITS ETF PLC - L&G Healthcare Breakthrough UCITS ETF AccumUSD (DOCT) 1 year Net Flows: $145M
DOCT ETF News
DOCT ETF FAQ
What was GB:DOCT’s price range in the past 12 months?
GB:DOCT lowest ETF price was $11.31 and its highest was $16.15 in the past 12 months.
What is the AUM of GB:DOCT?
As of Jun 19, 2026 The AUM of GB:DOCT is 242.77M.
Is GB:DOCT overvalued?
According to Wall Street analysts GB:DOCT’s price is currently Undervalued.
Does GB:DOCT pay dividends?
GB:DOCT does not currently pay dividends.
How many shares outstanding does GB:DOCT have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:DOCT?
Currently, no hedge funds are holding shares in GB:DOCT
DOCT ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Twist Bioscience
2.34%
Arrowhead Pharmaceuticals, Inc.
2.20%
Natera Inc.
2.11%
Tempus AI, Inc. Class A
2.07%
Guardant Health
2.06%
AxoGen
2.06%
LivaNova PLC
2.01%
Vertex Pharmaceuticals Inc.
1.99%
Stryker Corp
1.98%
Thermo Fisher Scientific
1.93%
Total20.75%
See All Holdings


